In contrast to CCD-18 Co cells, both individual treatments and the combination treatment significantly increased cell surface protein expression of DR4, DR5 and Fas in both colorectal carcinoma cell lines (Figure 4B,C). This evidence concerns the gene FAS and colorectal carcinoma.